Search by Drug Name or NDC
NDC 00078-0862-25 DUREZOL 0.5 mg/mL Details
DUREZOL 0.5 mg/mL
DUREZOL is a OPHTHALMIC EMULSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is DIFLUPREDNATE.
MedlinePlus Drug Summary
Difluprednate ophthalmic is used to treat eye swelling and pain after eye surgery. Difluprednate ophthalmic is in a class of medications called corticosteroids. It works by stopping the release of certain natural substances that cause swelling and pain.
Related Packages: 00078-0862-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Difluprednate Ophthalmic
Product Information
| NDC | 00078-0862 |
|---|---|
| Product ID | 0078-0862_fc48eb8f-ff3a-4919-bee4-8cc850834f2a |
| Associated GPIs | |
| GCN Sequence Number | 064354 |
| GCN Sequence Number Description | difluprednate DROPS 0.05 % OPHTHALMIC |
| HIC3 | Q6P |
| HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
| GCN | 13635 |
| HICL Sequence Number | 011782 |
| HICL Sequence Number Description | DIFLUPREDNATE |
| Brand/Generic | Brand |
| Proprietary Name | DUREZOL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | difluprednate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | EMULSION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | DIFLUPREDNATE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022212 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0862-25 (00078086225)
| NDC Package Code | 0078-0862-25 |
|---|---|
| Billing NDC | 00078086225 |
| Package | 1 BOTTLE in 1 CARTON (0078-0862-25) / 5 mL in 1 BOTTLE |
| Marketing Start Date | 2022-07-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 41.6957 |
| Pricing Unit | ML |
| Effective Date | 2023-08-23 |
| NDC Description | DUREZOL 0.05% EYE DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis